Hepatitis C is an infectious disease caused by human infection with the hepatitis C virus that is mainly transmitted through blood. Currently in China, 50%-85% of acute hepatitis C develops into chronic hepatitis, and many patients progress due to no significant changes in liver function, but the disease progresses and develops into cirrhosis after more than 20 years of infection a few patients progress into liver cancer. It is only at the advanced stage of the disease that the patient is seen in hospital and the best time for treatment is lost. This disease is not easily detected and creates a large undiagnosed group of chronic hepatitis C in the society, which is also a very dangerous and hidden source of infection and therefore extremely harmful to people. Therefore, as soon as hepatitis C virus replication is detected, it must be treated actively and in a timely manner. The prognosis for hepatitis C is better than that of hepatitis B. Unlike hepatitis B, which cannot be completely cured, hepatitis C can be cured by early detection and treatment in more than 50-60% of patients. The most effective treatment for hepatitis C is a interferon combined with ribavirin, and in recent years there has been a significant efficacy of pegylated interferon compared to ordinary interferon, and pegylated interferon combined with ribavirin can completely cure more than 60% of hepatitis C. The key is early detection and early treatment. I hope that the majority of hepatitis C patients must seek medical attention as soon as possible, timely treatment, will have a better prognosis, will be from the new health!